Summary
The product Tirzepatide transparent pink top vial, submitted by Alchemist Peptides, underwent independent testing to verify its composition and purity. The sample, identified by Task Number #45426, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis confirmed a Tirzepatide content of 5.54 mg with a purity of 99.852%, indicating a high level of product quality.
The testing process began on 4 July 2024, with the sample received on 15 July 2024, and analysis completed on 17 July 2024. While the results confirm high purity, it is crucial to recognize that manufacturer-submitted samples may represent selectively chosen batches. This underscores the importance of further independent third-party testing to ensure consistency across the broader market. This report serves as an educational resource to promote informed decision-making and harm reduction.
Detailed Report
Product Overview
- Manufacturer: Alchemist Peptides
- Product Name: Tirzepatide transparent pink top vial
- Active Ingredient: Tirzepatide
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Raw Powder
Testing Details
- Task Number: #45426
- Testing Ordered: 4 July 2024
- Sample Received: 15 July 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Alchemist Peptides (Manufacturer)
- Analysis Paid For By: Alchemist Peptides (Manufacturer)
Testing Results
- Specification: Not explicitly stated
- Measured Concentration: 5.54 mg
- Purity: 99.852%
Verification Details
- Verification URL: https://janoshik.com/tests/45426_6NN599RU6RAP
Evaluation of Manufacturer-Submitted Testing
This analysis confirms the high purity of the tested Tirzepatide product but raises the need for careful consideration due to its submission by Alchemist Peptides. Manufacturer may select high-quality batches for testing, which may not fully reflect the consistency of the product across all available stock. While Janoshik Analytical is recognized for its rigorous testing protocols, independent validation through third-party testing remains essential to ensure broader product reliability.
Conclusion
The test results verify that the Tirzepatide transparent pink top vial contains 5.54 mg of active ingredient with an impressive 99.852% purity. While this indicates strong quality control for this batch, further testing across multiple batches is recommended to ensure consistency. This report is intended for educational and harm reduction purposes, assisting consumers in making informed decisions regarding peptide products.
Disclaimer
This report is published solely for educational and harm reduction purposes. As the testing was initiated by the manufacturer, potential biases may exist. However, the data provided remains valuable when assessed alongside independent third-party results. Consumers are encouraged to evaluate this information responsibly.
